MGX · Company research
Metagenomi Therapeutics, Inc. Common Stock (MGX): Valuation Analysis
Available valuation snapshots and ratios; unavailable metrics remain blank.
RESEARCH CONTEXT
Understand the numbers
Available valuation snapshots and ratios; unavailable metrics remain blank. Use period, currency, units and source fields when interpreting values.
1records availableHealthcare
Valuation Analysis data
Database-backed records only
| valuation date | price | market cap | enterprise value | pe | forward pe | peg | price sales | price book | price fcf |
|---|---|---|---|---|---|---|---|---|---|
| Oct 8, 2026 | 0.9847 | $42,842,447.16 | 17536447.16 | — | — | — | 34.3288839423076923 | 0.31093694640200312080 | — |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.